Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: The INCREASE study
- Idris Bahce*
- , Chris Dickhoff
- , Famke L. Schneiders
- , Joris Veltman
- , David J. Heineman
- , Sayed M. S. Hashemi
- , Anne Vrijmoet
- , Ilias Houda
- , Ezgi B. Ulas
- , Joyce Bakker
- , Peter van de Ven
- , Natalja Bouwhuis
- , Lilian J. Meijboom
- , Daniela E. Oprea-Lager
- , Febe van Maldegem
- , Marieke F. Fransen
- , Tanja D. de Gruijl
- , Teodora Radonic
- , Suresh Senan
*Corresponding author for this work
- Affiliatie VU
- Pulmonary Care
- AII - Immunology
- CCA - Cancer Treatment and quality of life
- CCA - Cancer biology and immunology
- CCA - Imaging and biomarkers
- Cardiothoracic Surgery
- Surgery
- Radiation Oncology
- Affiliatie UvA
- Cancer Center Amsterdam
- IOO
- Doctoral School
- Pharmacy and Clinical Pharmacology
- Radiology and Nuclear Medicine
- Molecular Cell Biology and Immunology
- Medical Oncology Laboratory
- Pathology
- Amsterdam UMC - Vrije Universiteit Amsterdam
- Amsterdam UMC
- Vrije Universiteit Amsterdam
Research output: Contribution to journal › Article › Academic › peer-review
51
Downloads
(Pure)